AKT1 and prostate carcinoma: LNCaP cell transfection studies with an Akt1 overexpression vector indicate that this effect may be mediated through the inhibition of the protein kinase B (Akt)/NF-kB/MMP-9 cascade pathway, which results in diminished invasiveness of the prostate cancer cells [260].